5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Herney A. García-Perdomo; Hugo E. Lopez; James Tacklind

doi:10.1002/14651858.CD011928

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Herney A. García-Perdomo
, Hugo E. Lopez
, James Tacklind

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

Original language	English
Article number	CD011928
Journal	Cochrane Database of Systematic Reviews
Volume	2015
Issue number	11
DOIs	https://doi.org/10.1002/14651858.CD011928
State	Published - 04 Nov 2015
Externally published	Yes

Access to Document

10.1002/14651858.CD011928

Cite this

@article{c15f0227d3e448af935412064f74dd24,

title = "5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).",

author = "Garc{\'i}a-Perdomo, \{Herney A.\} and Lopez, \{Hugo E.\} and James Tacklind",

note = "Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",

year = "2015",

month = nov,

day = "4",

doi = "10.1002/14651858.CD011928",

language = "English",

volume = "2015",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

AU - García-Perdomo, Herney A.

AU - Lopez, Hugo E.

AU - Tacklind, James

PY - 2015/11/4

Y1 - 2015/11/4

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

UR - https://www.scopus.com/pages/publications/85041748285

U2 - 10.1002/14651858.CD011928

DO - 10.1002/14651858.CD011928

M3 - Article

AN - SCOPUS:85041748285

SN - 1465-1858

VL - 2015

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD011928

ER -

5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Abstract

Access to Document

Other files and links

Fingerprint

Cite this